Men who have just had their cancerous prostate gland removed have one pressing question for their doctors: Am I cured? But conventional tests haven’t been sensitive enough to provide a concrete answer. Current tests that measure the level of protein called PSA (prostate-specific antigen), which signals the presence of [...]
Prostate cancer patients on leuprolide who were offered to continue on FIRMAGON (degarelix for injection) after one year of treatment reduced prostate specific antigen (PSA) recurrence, according to results of a Phase III extension study(1) presented here at the American Urological Association 2010 meeting. PSA is commonly used [...]
Few people are taking advantage of pills that have been proven to prevent a substantial number of common cancers. If you didn’t realize such pills exist, you are not unusual. Which is part of the problem. This barely used arsenal in the war on cancer has grown to four drugs [...]
Scientists discuss in ‘Intensity-modulated radiation therapy with noncoplanar beams for treatment of prostate cancer in patients with bilateral hip prosthesis-a case study’ new findings in prostate cancer. Megavoltage photon intensity-modulated radiation therapy (IMRT) is typically used in the treatment of prostate cancer at our institution. Approximately 1% to [...]
An experimental drug is showing promise for the treatment of men with an aggressive form of advanced prostate cancer. A new multicenter study has concluded that the targeted therapy MDV3100 is safe and effective for patients with castration-resistant prostate cancer (CRPC), known for its poor prognosis and limited [...]
The most commonly used prostate cancer screening procedure, PSA, is at the center of a growing debate after its discoverer said it had become a hugely expensive public health disaster. In a commentary in The New York Times, Richard Ablin of the University of Arizona said the screening tool [...]
Kinex Pharmaceuticals opened a Phase 2 clinical trial to evaluate the safety and efficacy of KX2- 391 in patients with bone-metastatic, castrate- resistant prostate cancer (CRPC) who have not had prior chemotherapy.
Calypso Medical Technologies, Inc., a developer of targeting technology used for accurate, precise real-time tracking of tumor targets, today announced the online publication of a clinical study in Urology (The GOLD JOURNAL). The prospective, multi-site study, entitled, “Assessing the Impact of Margin Reduction (AIM),” is the first outcomes-based study to evaluate the quality of life [...]
Nearly half the people who need potentially lifesaving checks for colorectal cancer miss them, despite years of public effort in the United States to make colon screening as widespread as tests for breast and prostate cancer.
Your New Year’s resolution could also help fend off cancer. Quitting smoking is a no-brainer when it comes to reducing the chances of lung cancer. But did you know that putting down that cigarette for good can also lessen your chances of getting breast, prostate and bladder cancer? There’s [...]
The effectiveness of PSA (prostate-specific antigen) screening on reducing prostate cancer mortality has been given a boost with new data from the European Randomized Study of Screening for Prostate Cancer (ERSPC). This shows the true impact to be far higher than previously reported – up to 31%.
Watson Pharmaceuticals, Inc. today announced a new program encouraging health professionals to help maintain the bone health of prostate cancer patients who are on long-term androgen deprivation therapy (ADT). Nearly two million men are receiving ADT, a palliative treatment for prostate cancer that, while highly effective and considered [...]
A long-term study has found that men with low- grade, slow-growing prostate cancer who are managed with active surveillance and no radical treatment have an extremely high survival rate.
Ubiquitous Coriolus Mushroom vs. Cancer – healtharticlescentral.com
08/17/2009
Known in English as Turkey Tail, Coriolus versicolor is a contender for the title “World’s Most Common Mushroom.” You can find it from tropical rain forests to the Siberian taiga, feasting on dead wood.
Dendreon signs lease agreement with Majestic Realty to build new facility in Georgia – [...]
Cellular senescence is a persistently growth- arrested phenotype in normal and transformed cells induced by noncytotoxic stress. Cytostasis as a method of cancer treatment has recently generated significant interest, researchers in the United States report.
The largest single-institution study of its kind has found few complications in prostate cancer patients treated with radiotherapy after surgery to remove the prostate. Men in this study received radiotherapy after a prostate-specific antigen (PSA) test following surgery indicated their cancer had recurred.